Prolonged continuous infusion of low-dose rIL-2
1994
Comment on T-cell Activation During Low-Dose IL-2 Therapy
Commentary
Author Information
Author(s): R.A.J. Janssen, J. Buter, T.H. The', N.H. Mulder, L. de Leij
Primary Institution: University Hospital
Hypothesis
Does low-dose IL-2 therapy induce T-cell activation?
Conclusion
Low-dose IL-2 therapy can induce T-cell activation, but only temporarily in the first week of treatment.
Supporting Evidence
- Previous studies have shown T-cell activation during low-dose IL-2 therapy.
- IL-2 therapy may cause T-cell anergy, leading to decreased activated T cells.
- Early events in IL-2 therapy are crucial for understanding T-cell activation.
Takeaway
This study says that giving a low dose of a medicine called IL-2 can help activate certain immune cells called T cells, but this only happens for a short time at the beginning.
Methodology
The authors comment on previous studies and provide insights based on their own longitudinal study.
Want to read the original?
Access the complete publication on the publisher's website